Geode Capital Management’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,329,394
Closed -$120M 4594
2025
Q4
$120M Sell
2,329,394
-332,335
-12% -$16M 0.01% 960
2025
Q3
$131M Buy
2,661,729
+156,424
+6% +$8.02M 0.01% 916
2025
Q2
$130M Sell
2,505,305
-35,673
-1% -$1.64M 0.01% 867
2025
Q1
$119M Buy
2,540,978
+148,623
+6% +$7.67M 0.01% 876
2024
Q4
$123M Sell
2,392,355
-27,382
-1% -$1.42M 0.01% 876
2024
Q3
$108M Buy
2,419,737
+22,549
+0.9% +$986K 0.01% 949
2024
Q2
$96.4M Buy
2,397,188
+52,289
+2% +$1.98M 0.01% 939
2024
Q1
$94M Buy
2,344,899
+50,991
+2% +$1.92M 0.01% 953
2023
Q4
$86.4M Buy
2,293,908
+83,496
+4% +$2.55M 0.01% 954
2023
Q3
$61.5M Buy
2,210,412
+60,109
+3% +$1.88M 0.01% 1091
2023
Q2
$65M Buy
2,150,303
+96,716
+5% +$2.83M 0.01% 1064
2023
Q1
$63.3M Buy
2,053,587
+42,010
+2% +$1.6M 0.01% 1013
2022
Q4
$75.5M Buy
2,011,577
+66,774
+3% +$2.65M 0.01% 873
2022
Q3
$72.9M Buy
1,944,803
+80,479
+4% +$3.19M 0.01% 840
2022
Q2
$67.2M Sell
1,864,324
-17,910
-1% -$741K 0.01% 915
2022
Q1
$92.2M Sell
1,882,234
-72,584
-4% -$3.67M 0.01% 818
2021
Q4
$93.6M Buy
1,954,818
+111,870
+6% +$5.3M 0.01% 872
2021
Q3
$80.9M Sell
1,842,948
-56,014
-3% -$2.37M 0.01% 930
2021
Q2
$83.3M Buy
1,898,962
+36,271
+2% +$1.7M 0.01% 909
2021
Q1
$85.2M Buy
1,862,691
+79,102
+4% +$3.31M 0.01% 866
2020
Q4
$57.7M Buy
1,783,589
+116,997
+7% +$3.38M 0.01% 1000
2020
Q3
$35.3M Sell
1,666,592
-75,212
-4% -$1.57M 0.01% 1112
2020
Q2
$35.8M Buy
1,741,804
+3,676
+0.2% +$71.1K 0.01% 1088
2020
Q1
$30.5M Buy
1,738,128
+51,463
+3% +$1.59M 0.01% 1028
2019
Q4
$66.1M Sell
1,686,665
-12,021
-0.7% -$442K 0.01% 782
2019
Q3
$60.7M Sell
1,698,686
-18,068
-1% -$648K 0.01% 781
2019
Q2
$60.1M Buy
1,716,754
+95,258
+6% +$3.31M 0.01% 783
2019
Q1
$55.7M Buy
1,621,496
+5,761
+0.4% +$211K 0.01% 782
2018
Q4
$51.7M Buy
1,615,735
+528,022
+49% +$19.9M 0.02% 715
2018
Q3
$49.8M Buy
1,087,713
+19,845
+2% +$999K 0.01% 808
2018
Q2
$56.4M Buy
1,067,868
+16,272
+2% +$865K 0.02% 703
2018
Q1
$52.5M Buy
1,051,596
+43,283
+4% +$2.18M 0.02% 704
2017
Q4
$48.3M Sell
1,008,313
-18,139
-2% -$859K 0.02% 717
2017
Q3
$47.3M Buy
1,026,452
+74,188
+8% +$3.22M 0.02% 703
2017
Q2
$42.1M Buy
952,264
+17,273
+2% +$726K 0.02% 729
2017
Q1
$38.4M Buy
934,991
+56,289
+6% +$2.35M 0.02% 754
2016
Q4
$36.1M Buy
878,702
+33,112
+4% +$1.22M 0.02% 733
2016
Q3
$27.5M Buy
845,590
+34,624
+4% +$1.09M 0.01% 802
2016
Q2
$23.5M Sell
810,966
-5,181
-0.6% -$157K 0.01% 842
2016
Q1
$23.6M Buy
816,147
+1,149
+0.1% +$32.9K 0.01% 828
2015
Q4
$26.4M Sell
814,998
-4,937
-0.6% -$157K 0.02% 755
2015
Q3
$24.3M Buy
819,935
+22,951
+3% +$703K 0.01% 776
2015
Q2
$24.6M Buy
796,984
+24,051
+3% +$696K 0.01% 819
2015
Q1
$21.6M Buy
772,933
+54,617
+8% +$1.48M 0.01% 880
2014
Q4
$19.5M Buy
718,316
+4,618
+0.6% +$117K 0.01% 881
2014
Q3
$16.9M Buy
713,698
+2,943
+0.4% +$70.6K 0.01% 920
2014
Q2
$17.3M Buy
710,755
+21,313
+3% +$497K 0.01% 936
2014
Q1
$16.4M Buy
689,442
+8,678
+1% +$211K 0.01% 926
2013
Q4
$17.2M Sell
680,764
-6,887
-1% -$162K 0.01% 865
2013
Q3
$15.9M Buy
687,651
+201,862
+42% +$4.6M 0.01% 798
2013
Q2
$9.93M Buy
+485,789
New +$9.2M 0.01% 960

Other funds holding SNV

Geode Capital Management's SNV Position: Q1 2026 in Review

Geode Capital Management sold out of Synovus (SNV) in Q1 2026, closing a stake of 2,329,394 shares — an estimated $120M sold.

Geode Capital Management first reported a position in SNV in Q2 2013 and held it in 51 quarters. The position peaked at $131M in Q3 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Geode Capital Management reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 2,329,394 Synovus shares in Q1 2026, an estimated $120M.
  • Geode Capital Management first reported a position in Synovus in Q2 2013 and held it in 51 quarters.
  • Geode Capital Management's Synovus position peaked at $131M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.